Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Ms. Michelle Keefe

Market Cap

4.46 Billion USD

Sector

Healthcare

Website

https://www.syneoshealth.com

Last Update

2/22/2024, 12:00:00 PM

Description

Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America.

Read More

Overview

Value

33

Growth

53

Health

45

Management

42

Analyst Opinion

80

Total

51

All Scores Out Of 100

Best Features

  • Has a low level of debt
  • Has a history of share buybacks
  • Has a margin-of-safety above fair value
  • Liked by analysts
  • Low preportion of income is paid as dividend

Risk Factors

  • Earnings have declined recently
  • Disliked by Twitter users
  • Price-to-earnings ratio of 61.4 is higher than the market average (19.6x)
  • Dividend could be at risk

Market Peers

SYNH

Key Figures

PE Ratio (TTM)

61.40

Margin Of Safety (DCF)

67.67%

Revenue Growth (5 Year Average)

15.61%

Ratings Consensus

Buy

Share Buybacks

0.28%

Dividend Yeild (TTM)

0.00%

Valuation

Value Score

33

  • Margin-of-safety of 67.67% is better than the market average (17.95%)
  • Estimated intrinsic-value of 72.07 USD is higher than current price ( 42.98 USD)
  • Price-to-earnings ratio of 61.4 is higher than the market average (19.6x)
  • Free-cashflow-yeild of 3.63% is worse than the market average (4.7%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: < 71.3 USD

Current Price: 43 USD

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

61.40x

Free Cashflow Yeild

3.63%

PE/Earnings Growth

2.77

Price/Book

1.28x

Growth

Growth Score

53

  • 5 Year Average Revenue growth of 15.61% is higher than the market average (10.97%)
  • 5 Year Average Earnings growth of 16.43% is higher than the market average (14.48%)
  • Revenue growth has slowed this year
  • Earnings growth has slowed this year
  • 5 Year Average Free Cashflow growth of 4.78% is lower than the market average (12.35%)
  • Free Cashflow growth has slowed this year

Revenue Growth

15.61%

Earnings Growth

16.43%

Cashflow Growth

4.78%

Health

Health Score

45

  • Assets cover liabilities
  • Has a high level of debt
  • High financial leverage and base interest rate exposure
  • Requires debt for normal operation to be sustainable
  • Debt repayments significantly impact cashflow

Altman Z Score

1.44

Piostroski Score

7.00

Debt/Equity

0.90x

Current Assets/Liabilities

1.07x

Free Cashflow/Total Debt

0.13x

Debt/Capital

1.74x

Dividend

Secure Dividend Score

0

  • Long term dividend payout ratio of 0.00% is considered good
  • Payout ratio (TTM) of 0.00% is lower than the average (40%)
  • Dividends have shown growth over the last 5 years
  • Spending a lower percentage of their income on dividends than last 5 years
  • Dividend yeild of 0.00% is less than the market average (1.85%)
  • Very unsafe

Dividend Yeild

0.00%

Dividend Growth

0.00%

Payout Ratio (Earnings)

0.00%

Payout Ratio (Cashflow)

0.00%

Management

Management Score

42

  • Has a history of returning value to shareholders through stock buybacks
  • Return-on-capital-employed of 8.75% is lower than the market average (10%)
  • Has repurchased shares when overvalued
  • Return-on-equity of 6.87% is lower than the market average (15%)

Average Buybacks/Dilution

0.28%

Recent Buybacks/Dilution

-0.15%

5 Year Price Volitility

22.29%

Return On Assets

2.85%

Return On Capital Employed

8.75%

Return On Equity

6.87%

Return On Free Cashflow

N/A

Return On Investments

N/A

Social Sentiment

Social Sentiment Score

0

Twitter Sentiment

N/A

Stocktwits Sentiment

N/A

Analysts

Analyst Opinion

80

  • Ratings consensus is Buy

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

Syneos Health, Inc.

Currency

USD

Beta

1.58709

Vol Avg

2748086

Ceo

Ms. Michelle Keefe

Cik

0001610950

Cusip

87166B102

Exchange

NASDAQ Global Select

Full Time Employees

28768

Industry

Diagnostics & Research

Sector

Healthcare

Ipo Date

2014-11-07

Address

1030 Sync Street

City

Morrisville

State

NC

Country

US

Zip

27560-5468

Phone

919 876 9300

Analysis Last Updated

2/22/2024, 12:00:00 PM

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies